Protagonist Therapeutics, Inc.

PTGX·NasdaqGM·Healthcare
Compare
143.37+3.13 (+2.23%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market144.25+0.88 (+0.61%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close140.24
Open145.61
Day range138.62145.61
52-week range75.55160.81
Off day high−1.54%
Off 52-week high−10.85%
Volume713.42K
Avg. volume (3M)646.20K
Market cap9.28B
EPS (TTM)1.03
Forward P/E-1,444.39
P/E ratio (TTM)139.19
Dividend yield—
Beta (5Y)1.22
Shares outstanding64.71M
Short interest18.49% of float
Earnings dateAug 5, 2026 (est.)
Analyst target178.57
Profit margin29.40%

Against its peers

Compare in full ›
PTGX ROIV 688177.SS 688382.SS IOVA 8SJ.F
Market cap 9.28B 27.61B 7.38B 8.38B 3.94B 1.84B
P/E (TTM) 139.2 — — — — —
Forward P/E -1,444.4 -27.5 -26.2 -43.8 -44.4 —
Price/book 11.0 6.5 171.3 6.6 5.4 2.4
Dividend yield — — — — — —
1-year change +80.07% +85.85% −34.43% −48.70% +276.62% −37.59%
Today +2.23% +6.08% +2.95% +4.33% −1.47% +1.70%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All PTGX news ›
Markets Daily··2 outletsNegative

Protagonist Therapeutics (NASDAQ:PTGX) Stock Gets Downgrade from Wall Street Zen

Posted by Kim Johansen on Oct 12th, 2026 Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report issued on Saturday,…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

10mentions in 30 days
10with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance